Telix Pharmaceuticals Limited (TLX)
Nasdaq: TLX · Pharmaceutical Preparations · North Melbourne, AU · filing with the SEC since 2024
Who runs Telix Pharmaceuticals Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Behrenbruch Christian
MD & Group CEO. First filing Mar 2026, latest May 6, 2026, 1 filing in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
10 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Smith Darren Charlton | Group Chief Financial Officer | Mar 2026 | Sep 14, 2026 | none |
| Behrenbruch Christian | MD & Group CEO | Mar 2026 | May 6, 2026 | none |
| Patti Darren Joel | Group Chief Operating Officer | Apr 2026 | Apr 1, 2026 | none |
| Cade David Norman | Group Chief Medical Officer | Apr 2026 | Apr 1, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gill David N | director | May 2026 | May 18, 2026 | none |
| Jellison William R | director | May 2026 | May 18, 2026 | none |
| Rivas Maria | director | May 2026 | May 18, 2026 | none |
| Nelson Mark Alexander | director | Apr 2026 | Apr 1, 2026 | none |
| Mcdonald Marie Elizabeth | director | Mar 2026 | Mar 18, 2026 | none |
| Skinner Jann Elizabeth | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.